Fidelity Investments’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270M | Sell |
|
|||||
|
2025
Q1 | $247M | Sell |
|
|||||
|
2024
Q4 | $343M | Buy |
|
|||||
|
2024
Q3 | $250M | Buy |
|
|||||
|
2024
Q2 | $160M | Sell |
|
|||||
|
2024
Q1 | $220M | Buy |
|
|||||
|
2023
Q4 | $232M | Buy |
|
|||||
|
2023
Q3 | $194M | Buy |
|
|||||
|
2023
Q2 | $172M | Buy |
|
|||||
|
2023
Q1 | $10.2M | Buy |
|
|||||
|
2022
Q4 | $1.95M | Sell |
|
|||||
|
2022
Q3 | $6.52M | Sell |
|
|||||
|
2022
Q2 | $6.26M | Buy |
|
|||||
|
2022
Q1 | $13.2M | Hold |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|